Artwork

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials

34:04
 
Share
 

Manage episode 400064984 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

touchEXPERT OPINIONS for touchONCOLOGY

Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.

The experts

  • Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
  • Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
  • Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://touchoncologyime.org/eo-in-rrmm

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 400064984 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

touchEXPERT OPINIONS for touchONCOLOGY

Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.

The experts

  • Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
  • Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
  • Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://touchoncologyime.org/eo-in-rrmm

  continue reading

102 episodes

Todos los episodios

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide